Small NBFC
Market Cap
₹3,471 ₹3,471 Cr.
P/E
40.87
PEG
1.75
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes alive if FY27 consolidated revenue guidance and the dialysis-centre rollout execute as planned, with sickle-cell testing commercialisation validating the later healthcare ramp.

The bull path depends on commercial revenue from Onco Spectra and TB Truth plus successful dialysis execution, while the bear path reflects guidance misses, rollout shortfalls, delayed healthcare adoption or slower renewable-energy order-book conversion.

Financial

Business

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material